Informazioni su Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. was a pharmaceutical company headquartered in South San Francisco, California that developed and marketed cancer treatment medications. It was founded and incorporated with the California Secretary of State in February 1992 by venture capitalist Kevin J. Kinsella and Frank McCormick, Ph.D., FRS, D.Sc. (Hon.), a renowned British-American biochemist. McCormick served as the chief scientific officer until 1996, while Kinsella chaired the company's board of directors. On March 26, 1996, Onyx withdrew its corporate registration with the California Secretary of State and reincorporated in the state of Delaware in advance of successfully taking the company public on the NASDAQ exchange using National Market symbol ONXX on May 9, 1996. In 2009, the company acquired private biotechnology company Proteolix for US$276 million in cash plus additional milestone payments. In January 2012, the company was named "the top biotechnology takeover target in 2012" in an industry survey conducted by the ISI Group. Onyx president and CEO N. Anthony Coles had said that Onyx liked its prospects as an independent company and was focused on bringing new therapies to patients. However, by the end of August 2013, Amgen announced that it was acquiring Onyx in an agreed US$10.4 billion deal.
Source: Wikipedia
SedeCorporation Trust Center, 1209 Orange Street, 19801, Wilmington, US
Fondato2013
StatoAttivo
Brevetti60 brevetti
METHODS OF TREATING MULTIPLE MYELOMA USING BCL-2 INHIBITOREP4558143A4 · 2026
Methods of treating multiple myelomaUS12636340B2 · 2026
Accedi per vedere tutti i 60 brevetti
Consulta l'intero portafoglio di brevetti, con numeri di pubblicazione, date e famiglie.
Accedi Crea un account con la tua emailÈ gratis
Continuando, accetti il Contratto utente, l'Informativa sulla privacy e l'Informativa sui cookie di Heelky.
Recensioni
Ancora nessuna recensione. Hai lavorato con Onyx Pharmaceuticals, Inc.? Sii il primo a condividere la tua esperienza.
Informazioni legali
| Ragione sociale | Onyx Pharmaceuticals, Inc. |
|---|---|
| LEI | 549300K47GO90N8J4853Vedi su GLEIF ↗ |
| Sede legale | Corporation Trust Center, 1209 Orange Street, 19801, Wilmington, US |
| Stato | Attivo |
Fonti: GLEIF · aggiornato 16 ottobre 2026
Contatti e link
Posizione
Corporation Trust Center, 1209 Orange Street, 19801, Wilmington, US
È la tua azienda?
Rivendica gratis questa pagina per aggiungere logo, prodotti, foto e offerte di lavoro e per rispondere alle recensioni.
Rivendica questa paginaUnisciti a Heelky per entrare in contatto, assumere e crescere
Crea un account gratuito per inviare messaggi, candidarti alle offerte di lavoro e pubblicare missioni.
Iscriviti ora — è gratis